Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | BLM | P54132 | 2/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | WRN | Q14191 | 1/20 | 0.38 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.38 |
| ▸ | GSK3A | P49840 | 1/20 | 0.37 |
| ▸ | GSK3B | P49841 | 1/20 | 0.37 |
| ▸ | MGLL | Q99685 | 3/20 | 0.30 |
| ▸ | GMNN | O75496 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | THPO | P40225 | 1/20 | 0.30 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.30 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.30 |
| ▸ | FAAH | O00519 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2581743 | 0.82 | ALDH1A1 (0.41) | ALDH1A1BLMCYP1A2HPGDCYP2C19 | |
| SCHEMBL269178 | 0.82 | ALDH1A1 (0.41) | ALDH1A1BLMCYP1A2HPGDCYP2C19 | |
| SCHEMBL28991876 | 0.78 | ALDH1A1 (0.38) | ALDH1A1BLMCYP1A2HPGDCYP2C19 | |
| SCHEMBL22203032 | 0.78 | ALDH1A1 (0.38) | ALDH1A1BLMCYP1A2HPGDCYP2C19 | |
| SCHEMBL558062 | 0.78 | ALDH1A1 (0.57) | ALDH1A1BLMCYP1A2HPGDCYP2C19 | |
| SCHEMBL28390950 | 0.78 | ALDH1A1 (0.38) | ALDH1A1BLMCYP1A2HPGDCYP2C19 | |
| SCHEMBL16862478 | 0.78 | ALDH1A1 (0.38) | ALDH1A1BLMCYP1A2HPGDCYP2C19 | |
| SCHEMBL9809890 | 0.78 | ALDH1A1 (0.38) | ALDH1A1BLMCYP1A2HPGDCYP2C19 | |
| SCHEMBL28928300 | 0.78 | ALDH1A1 (0.38) | ALDH1A1BLMCYP1A2HPGDCYP2C19 | |
| SCHEMBL28100145 | 0.78 | ALDH1A1 (0.35) | ALDH1A1BLMCYP1A2HPGDCYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120035320-A1 | POLYACRIDINE NUCLEIC ACID DELIVERY PEPTIDE COMPLEXES | UNIVERSITY OF IOWA RESEARCH FOUNDATION (US) | 2012-02-09 | — | — | US | disclosed |
| CN-102216779-A | Method for the preparation of immunoconjugates and use thereof | XEPTAGEN SPA | 2011-10-12 | — | — | CN | disclosed |
| EP-0847991-A1 | Method for the preparation of N-(carboxyalkyl) imides | DAINIPPON INK AND CHEMICALS, INC. (JP) | 1998-06-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120035320-A1 | POLYACRIDINE NUCLEIC ACID DELIVERY PEPTIDE COMPLEXES | NUP205, PABPC1, SARNP | ALDH1A1 3315/4885BLM 545/4885CYP1A2 4881/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.